Meet the mAbs: the new treatments for vulnerable patients with COVID-19

There have been some promising trial results recently regarding the efficacy of monoclonal antibodies (or mAbs) in patients with COVID-19. In this podcast, features editor Dawn Connelly and clinical and science editor Julia Robinson investigate the science behind these exciting new treatments and the potential role of pharmacists in preparing, supplying and assessing patients for their use. Robinson also visits the aseptics lab at King's College Hospital in London to find out from senior pharmacist James Cheung how mAbs are made. With thanks to associate professor Al Edwards from the Reading School of Pharmacy and PJ deputy news editor Carolyn Wickware for their help in preparing this podcast. This episode was produced by Geoff Marsh. Our exclusive on NHS plans for a community-based mAbs service: https://tinyurl.com/mabsservice Here is a link to more information on the clinical trials discussed in this podcast: tinyurl.com/COVIDtxs Sign up for our daily, weekly or monthly newsletters to hear more from The Pharmaceutical Journal: https://pharmaceutical-journal.com/pr... This content was developed for healthcare professionals.